Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03723408
Other study ID # CLMD_CT_001
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 16, 2016
Est. completion date December 21, 2017

Study information

Verified date October 2018
Source ClearLine MD
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

There is widespread acceptance that air in intravenous (IV) fluid tubing (lines) can pose a significant risk to patients.1 A rigorous literature search regarding sources of this air identified only anecdotal and non-clinical work regarding the presence and sources of air in IV tubing. Most published case studies have focused on air entrainment from accidental or inadvertent sources - empty IV fluid bags, incomplete priming of the tubing prior to infusion, and air-detection device failures, as examples.

The sources (and volume) of air inside IV tubing during common surgical procedures or interventions have yet to be studied prospectively. Understanding the frequency and magnitude of the presence of unintended air in IV tubing is the first step in devising potential avoidance strategies for eliminating unintended air in IV tubing. This study was designed to identify both the sources and magnitude of air that occurs in IV tubing during routine surgical procedures.


Description:

Methods:

An observational prospective trial was conducted in operating room settings across multiple study sites. 120 surgical patients undergoing a variety of interventional and surgical procedures were selected, representing multiple patient populations, case types and anesthesia setups. The ClearLine IV, a device that detects and removes air from IV tubing, was inserted into the IV circuit. Clinicians followed standard protocols. Blood warmers were used at the practitioner's discretion. IV fluid was administered at a constant flow rate or through a bolus given over 30-60 seconds per standard of care. The volume and duration of fluid administration was recorded, along with the frequency, duration and amount of air captured by ClearLine IV.


Recruitment information / eligibility

Status Completed
Enrollment 120
Est. completion date December 21, 2017
Est. primary completion date December 21, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- Any age - both pediatric and adult

- Weight equal to or greater than 5kg

- Surgical procedures

- Cardiac catherization procedures

- Minimum two hours procedure time

Exclusion Criteria:

- Patient weight less than 5 kg

- Procedures not involving surgery or cardiac catherization

- Procedures less than two hours

Study Design


Related Conditions & MeSH terms


Intervention

Device:
ClearLine IV (formerly, AirPurge)
Patient safety device that automatically and continuously detects and actively removes air from IV lines - protecting patients from dangerous air burden, air embolism, air infusions.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
ClearLine MD

Outcome

Type Measure Description Time frame Safety issue
Primary The frequency of air removed from intravenous tubing by ClearLine IV The ClearLine IV data monitor measures the frequency (# of air masses) of air removed from IV lines 1 year
Primary The amount of air removed from intravenous tubing by ClearLine IV The ClearLine IV data monitor measures the amount (mL) of air removed from IV lines 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT02340741 - Insufflation of Carbon Dioxide During Cardiac Surgery as Prevention Neurologic Complications N/A
Recruiting NCT06168539 - Reduction of Microemboli of Air Using a New Developed Air Trap (EmbolessTM) During Haemodialysis N/A
Completed NCT05820828 - Comparing Air Embolic Load in Two Venous Cannulation Methods, 40 Patients Undergoing Elective Valve Surgery. N/A